GalChimia starts the process to be the first chemical company in Spain quoted in the MAB.

the Galician company aims to boost its internationalization process and enhance its capacity operational.

Santiago de Compostela, February 2012.- the Galician company GalChimia, a leader in Spain in services of synthetic organic chemistry oriented to the provision of advanced services to the pharmaceutical industry, has begun the process to quote in the market alternative investment market (aim).

GalChimia, headquartered in O Pino (A Coruña), will be the first Spanish company in the chemical industry listed in the MAB. The company announced its decision this morning, in the meeting of investors in the biotechnology cluster of Galicia (Bioga) in Santiago.

DCM Asesores will act as a consultant registered in the process, it intends to develop during the first half of the year. The company had also counselling goals BioTech, signature expert consulting services business to companies and investors in the life sciences sector.

With his departure to the MAB, the company will boost its internationalization process and will improve its operational capacity. GalChimia, founded in the year 2001, among others, by Carme Pampín and James crosses, develops high value-added services for the chemical, pharmaceutical and biotechnology industries in Europe and United States.

GalChimia boasts a portfolio of more than one hundred customers in 25 countries, among the Almirall, Palau Pharma and Esteve, pharmaceutical and biotechnological Noscira, Midatech, GenMedica Therapeutics and Neuron BPH.

The path of steady growth of GalChimia in recent years has led to the decision to quote in the MAB company. Despite the economic crisis, their participation in national and international projects increasing has been increasing and, since its inception, the firm has become the most prominent example of business success in his sector.

the MAB is a stock market that operates with small capitalization companies seeking to expand. Listed companies put into value your business and improve their competitiveness, as well as bring new ways of financing, visibility to investors, liquidity and an objective assessment.

Galchimia, founded in the year 2001, is a leader in the Spanish market in synthetic organic chemistry processes. The company works with pharmaceutical companies in Europe, United States.UU. and Asia. Currently the company is intensifying the process of internationalisation.